THELMA Therapeutics Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was KRW 7,704.39 million compared to KRW 3,814.62 million a year ago. Basic loss per share from continuing operations was KRW 133 compared to KRW 148 a year ago.

Basic loss per share was KRW 134 compared to KRW 149 a year ago.